NCT05380167

Brief Summary

The objective of this study was to determine the chronic effects of beetroot juice supplementation on the acute (90-minute post nitrate consumption) efficacy of converting dietary nitrate to plasma nitrate and plasma nitrite in healthy middle-to-older aged adults. the investigators were also interested in determining the effect of this intervention on fasting levels of plasma nitrate and nitrite over time. Furthermore, the number of participants classified as "non-responders" was determined based on increases in plasma nitrite achieved using tolerable volumes of beetroot juice by other studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

May 12, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 18, 2022

Completed
Last Updated

May 25, 2022

Status Verified

May 1, 2022

Enrollment Period

1.7 years

First QC Date

May 12, 2022

Last Update Submit

May 18, 2022

Conditions

Keywords

beetroot juicedietary nitrateplasma nitrite

Outcome Measures

Primary Outcomes (4)

  • Fasting Plasma Nitrate

    Concentration of nitrate in the plasma obtained at the start of each testing visit

    Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12

  • Fasting Plasma Nitrite

    Concentration of nitrite in the plasma obtained at the start of each testing visit

    Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12

  • 90 minute plasma Nitrate

    Concentration of nitrate in the plasma obtained 90 minutes following the consumption of the intervention arm's assigned beverage

    Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12

  • 90 minute plasma Nitrite

    Concentration of nitrite in the plasma obtained 90 minutes following the consumption of the intervention arm's assigned beverage

    Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12

Study Arms (2)

BRJ Nitrate

EXPERIMENTAL

This arm consumed daily for 12 weeks a 70 mL bottle of beetroot juice containing 380 mg of nitrate.

Dietary Supplement: BRJ Nitrate

BRJ Placebo

PLACEBO COMPARATOR

This arm consumed daily for 12 weeks a 70 mL bottle of beetroot juice containing 0 mg of nitrate.

Dietary Supplement: BRJ Placebo

Interventions

BRJ NitrateDIETARY_SUPPLEMENT

Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink with nitrate.

BRJ Nitrate
BRJ PlaceboDIETARY_SUPPLEMENT

Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink without nitrate

BRJ Placebo

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Middle and Older (40-80 year-old) men and women
  • Body mass index between 18.5 - 30.0 kg/m2
  • Able to provide own transportation to study testing visits
  • Able to consume study beverages
  • Able to speak and read English

You may not qualify if:

  • Tobacco user (smoke or chew), including e-cigarettes
  • Known conditions of: diabetes mellitus (type 1 or 2), atrophic gastritis, hypo- or hyperthyroidism, gout, history of kidney stones, history of hypotension, cardiovascular disease, chronic obstructive pulmonary disease, inflammatory bowel diseases, impaired liver or kidney function
  • Current or recent (last 3 months) treatment for cancer
  • Current use of the following medications: Phosphodiesterase type 5 inhibitors, nitroglycerin or nitrate preparations, proton pump inhibitors, medication for hypothyroidism, antacid and heartburn medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest University

Winston-Salem, North Carolina, 27109, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
A third party not involved with the conduct of the study provided research staff with the beetroot juice in participant specific coded bottles. The research staff then distributed these coded bottles to the participant. At the end of the trial, the code was revealed for intervention assignment.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will be randomized into one of two groups. The first group will consume daily beetroot juice containing 380 mg of nitrate and the second group will consume daily beetroot juice with nitrate removed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 18, 2022

Study Start

September 1, 2017

Primary Completion

May 1, 2019

Study Completion

May 1, 2019

Last Updated

May 25, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations